Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
3.09
20.62
667.31%
Share Warrants & Outstandings
Total Reserve
0.95
68.71
-67.76
-98.62%
Shareholder's Funds
24.65
71.80
-47.15
-65.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.11
-0.11
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.11
-0.11
-100.00%
Current Liabilities
Trade Payables
0.00
38.70
-38.70
-100.00%
Other Current Liabilities
0.14
0.94
-0.80
-85.11%
Short Term Borrowings
0.44
9.91
-9.47
-95.56%
Short Term Provisions
0.00
0.02
-0.02
-100.00%
Total Current Liabilities
0.57
49.58
-49.01
-98.85%
Total Liabilities
25.23
121.49
-96.26
-79.23%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
16.85
-16.80
-99.70%
Less: Accumulated Depreciation
0.01
6.37
-6.36
-99.84%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
10.48
-10.44
-99.62%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.44
-3.44
-100.00%
Long Term Loans & Advances
0.02
0.75
-0.73
-97.33%
Other Non Current Assets
0.00
3.46
-3.46
-100.00%
Total Non-Current Assets
0.07
18.13
-18.06
-99.61%
Current Assets Loans & Advances
Current Investments
0.00
0.36
-0.36
-100.00%
Inventories
0.00
38.01
-38.01
-100.00%
Sundry Debtors
0.60
56.54
-55.94
-98.94%
Cash and Bank
21.30
0.16
21.14
13,212.50%
Other Current Assets
0.00
0.17
-0.17
-100.00%
Short Term Loans and Advances
3.26
8.13
-4.87
-59.90%
Total Current Assets
25.16
103.36
-78.20
-75.66%
Net Current Assets (Including Current Investments)
24.59
53.78
-29.19
-54.28%
Total Current Assets Excluding Current Investments
25.16
103.00
-77.84
-75.57%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
121.49
-96.26
-79.23%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
9.91
-9.47
-95.56%
Book Value per share (adjusted)
10.40
232.39
-221.99
-95.52%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
